Check out this study authored by several researchers, including Dr. Stefan Gravenstein who recently presented at an AVAC briefing on Capitol Hill. The study is entitled Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season. The study found that the use of HD influenza vaccine in long-stay NH residents reduced total health care expenditures for a net benefit despite HD being more expensive per dose. These cost offsets applied to Medicare beneficiaries residing in NHs could result in important savings to the Medicare program.
New Study Examines Benefits of Influenza Vaccine Among Long-Term Care Population
This study was authored by several researchers, including Dr. Stefan Gravenstein who recently presented at an AVAC briefing on Capitol Hill. The study is entitled Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season. The study found that the use of HD influenza vaccine in long-stay NH residents reduced total health care expenditures for a net benefit despite HD being more expensive per dose. These cost offsets applied to Medicare beneficiaries residing in NHs could result in important savings to the Medicare program.